Sex and haemodynamics in pulmonary arterial hypertension

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Respiratory Journal

• Publication date

  2013-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09031936.00027613PMID 23949961PMCID PMC4338984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary Hypertension Surveillance

  2014cited by this paper
• Oestrogen and the sexual dimorphism of pulmonary arterial hypertension: a translational challenge

  2013cited by this paper
• Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways

  2012cited by this paper
• Survival in pulmonary hypertension in Spain: insights from the Spanish registry

  2012cited by this paper
• A Dominant Negative ERβ Splice Variant Determines the Effectiveness of Early or Late Estrogen Therapy after Ovariectomy in Rats

  2012cited by this paper
• Testosterone negatively regulates right ventricular load stress responses in mice

  2012cited by this paper
• Testosterone Supplementation in Heart Failure: A Meta-Analysis

  2012cited by this paper
• Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.

  2012cited by this paper
• Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry.

  2012cited by this paper
• Activity of the Estrogen-Metabolizing Enzyme Cytochrome P450 1B1 Influences the Development of Pulmonary Arterial Hypertension

  2012cited by this paper
• Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension.

  2012cited by this paper
• Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis

  2012cited by this paper
• Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.

  2012cited by this paper
• Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.

  2012cited by this paper
• Selective Serotonin Reuptake Inhibitor Use Is Associated with Right Ventricular Structure and Function: The MESA-Right Ventricle Study

  2012cited by this paper
• Sex and Race Differences in Right Ventricular Structure and Function: The Multi-Ethnic Study of Atherosclerosis–Right Ventricle Study

  2011cited by this paper
• Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry.

  2011cited by this paper
• Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study.

  2011influential reference
• Estrogen rescues preexisting severe pulmonary hypertension in rats.

  2011cited by this paper
• Long-term therapy with inhaled iloprost in patients with pulmonary hypertension.

  2010cited by this paper
• Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

  2010cited by this paper
• Adverse events associated with testosterone administration.

  2010cited by this paper
• Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)

  2010cited by this paper
• Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.

  2010cited by this paper
• Is pulmonary arterial hypertension really a late complication of systemic sclerosis?

  2010cited by this paper
• Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

  2010cited by this paper
• Tadalafil Therapy for Pulmonary Arterial Hypertension

  2009cited by this paper
• Association between Arterial Stiffness and Variations in Estrogen-Related Genes

  2009cited by this paper
• Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females

  2009cited by this paper
• Is pulmonary arterial hypertension really a late complication of systemic sclerosis?

  2009cited by this paper
• Determinants of right ventricular ejection fraction in pulmonary arterial hypertension.

  2009cited by this paper
• Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.

  2009cited by this paper
• Selective estrogen receptor-alpha and estrogen receptor-beta agonists rapidly decrease pulmonary artery vasoconstriction by a nitric oxide-dependent mechanism.

  2008cited by this paper
• Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2

  2008cited by this paper
• HRT and the young at heart.

  2007cited by this paper
• Estrogen therapy and coronary-artery calcification.

  2007cited by this paper
• Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

  2007cited by this paper
• Pulmonary arterial hypertension in France: results from a national registry.

  2006cited by this paper
• Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.

  2006cited by this paper
• Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.

  2006cited by this paper
• Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.

  2006cited by this paper
• Sildenafil citrate therapy for pulmonary arterial hypertension.

  2005cited by this paper
• Cryptosporidiosis Surveillance — United States 1999-2002 and

  2005cited by this paper
• Molecular and Cellular Basis of Cardiovascular Gender Differences

  2005cited by this paper
• Pulmonary hypertension surveillance--United States, 1980-2002.

  2005cited by this paper
• Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis : United States, 1988-1994 and 1909-2002

  2005cited by this paper
• Sitaxsentan therapy for pulmonary arterial hypertension.

  2004cited by this paper
• Chorioamnionitis and cerebral palsy in term and near-term infants

  2004cited by this paper
• Association between estrogen receptor α gene variation and cardiovascular disease

  2004cited by this paper
• Age and risk of pulmonary arterial hypertension in scleroderma.

  2003cited by this paper
• Estrogen plus progestin and the risk of coronary heart disease.

  2003cited by this paper
• Association between estrogen receptor alpha gene variation and cardiovascular disease.

  2003cited by this paper
• Bosentan therapy for pulmonary arterial hypertension.

  2002cited by this paper
• Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

  2002cited by this paper
• Inhaled iloprost for severe pulmonary hypertension.

  2002cited by this paper
• Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor β

  2002cited by this paper
• BOSENTAN THERAPY FOR PULMONARY ARTERIAL HYPERTENSION

  2002cited by this paper
• Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy

  2002cited by this paper
• Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension.

  2002cited by this paper
• Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

  2002cited by this paper
• Effects of Sex Hormones and Their Balance on the Proliferation of Rat Vascular Endothelial Cells

  2002cited by this paper
• Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression.

  2001cited by this paper
• Age and gender effects on cardiomyocyte apoptosis in the normal human heart.

  2001cited by this paper
• Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

  2001cited by this paper
• [Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study].

  2001cited by this paper
• Age at natural menopause and risk of cardiovascular disease.

  1999cited by this paper
• The normal menopause transition.

  1992cited by this paper
• The normal menopause transition

  1992cited by this paper
• Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

  1991cited by this paper
• Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery.

  1981cited by this paper
• Cardiopulmonary responses of male and female swine to simulated high altitude.

  1973cited by this paper
• The Normal Menopause

  1941cited by this paper

• Female Fibroblast Activation Is Estrogen-Mediated in Sex-Specific 3D-Bioprinted Pulmonary Artery Adventitia Models.

  2025cites this paper
• Sex differences in pulmonary (arterial) hypertension: does it matter?

  2025cites this paper
• Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY): A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

  2025cites this paper
• Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction.

  2025cites this paper
• Impact of Reproductive Factors and Hormone Replacement Therapy on Disease Severity in Women with Pulmonary Arterial Hypertension: Insights from the United States Pulmonary Hypertension Scientific Registry

  2025cites this paper
• Ovarian hormones attenuate right ventricular remodeling in a rat model of pulmonary arterial hypertension

  2025cites this paper
• Engineering HMGB1-derived Peptides to Unravel Sex-Specific Mechanisms in Pulmonary Arterial Hypertension

  2025cites this paper
• Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC

  2024cites this paper
• Extrapulmonary manifestations of pulmonary arterial hypertension

  2024cites this paper
• Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction

  2024cites this paper
• Investigating the “sex paradox” in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR)

  2024cites this paper
• Sex differences in the prevalence and survival of pulmonary hypertension in obstructive hypertrophic cardiomyopathy following septal myectomy

  2024cites this paper
• Respiratory Diseases in Women.

  2024cites this paper
• Contemporary Treatment of Pulmonary Arterial Hypertension: A US Perspective.

  2024cites this paper
• Sex-dependent Remodeling of Right-Ventricular Function in a Rat Model of Pulmonary Arterial Hypertension.

  2024cites this paper
• Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models

  2023cites this paper
• Sex- and Gender-Related Aspects in Pulmonary Hypertension.

  2023cites this paper
• Efficient uncertainty quantification in a spatially multiscale model of pulmonary arterial and venous hemodynamics

  2023cites this paper
• Insights into the relationship between serum uric acid and pulmonary hypertension (Review)

  2023cites this paper
• Treatment of pulmonary arterial hypertension: recent progress and a look to the future.

  2023cites this paper
• The HRCT Imaging Findings of the Peripheral Pulmonary Vessels in Patients with Pulmonary Hypertension (PH)

  2023cites this paper
• Sex matters: the frequently overlooked importance of considering sex in computational models

  2023cites this paper
• Retrospective cohort study of pulmonary arterial hypertension associated with connective tissue disease effect on patients’ prognosis

  2023cites this paper
• Dynamically stiffening biomaterials reveal age- and sex-specific differences in pulmonary arterial adventitial fibroblast activation

  2023cites this paper
• Remote evaluation of risk and physiological response to therapeutic escalation and clinical worsening in patients with pulmonary hypertension

  2023cites this paper
• The Future of PAH Treatment

  2023cites this paper
• Pathophysiology and new advances in pulmonary hypertension

  2023cites this paper
• Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.

  2023cites this paper
• Retinal vessel changes in pulmonary arterial hypertension

  2022cites this paper
• COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

  2022cites this paper
• Biomarkers in Pulmonary Arterial Hypertension

  2022cites this paper
• Sex and Gender in lung diseases and sleep disorders: A state of the art review. Part 2.

  2022cites this paper
• Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry

  2022influential citation
• Baseline Sex Differences in Pulmonary Arterial Hypertension Randomized Clinical Trials.

  2022cites this paper
• Research Status of Pulmonary Hypertension in Plateau Area

  2022cites this paper
• The Impact of Socioeconomic, Racial, and Ethnic Disparities on Pulmonary Hypertension Diagnosis and Treatment

  2022cites this paper
• Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease

  2022cites this paper
• Female rats are less prone to clinical heart failure than male rats in a juvenile rat model of right ventricular pressure load.

  2022cites this paper
• Sex Differences in Right Ventricular Adaptation to Pressure Overload in a Rat Model.

  2022cites this paper
• Sex and gender in pulmonary arterial hypertension

  2021cites this paper
• Hormones, Hemodynamics, and Hepatic Function: Digesting the Intricacies of Sex Differences in Portopulmonary Hypertension.

  2021cites this paper
• 17β-estradiol and estrogen receptor-α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin.

  2021cites this paper
• Sex Differences in Pulmonary Hypertension.

  2021cites this paper
• Sex difference in pulmonary hypertension in the evaluation by exercise echocardiography

  2021cites this paper
• Association of premature menopause with incident pulmonary hypertension: A cohort study

  2021cites this paper
• Potassium (K+) channels in the pulmonary vasculature: Implications in pulmonary hypertension Physiological, pathophysiological and pharmacological regulation.

  2021cites this paper
• Roles of Genetic Predisposition in the Sex Bias of Pulmonary Pathophysiology, as a Function of Estrogens : Sex Matters in the Prevalence of Lung Diseases.

  2021cites this paper
• STATE OF THE ART Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances

  2021cites this paper
• Sex Differences in Pulmonary Arterial Hypertension

  2021cites this paper
• Sex and Gender Differences in Lung Disease.

  2021cites this paper
• Age-changes in right ventricular function–pulmonary circulation coupling: from pediatric to adult stage in 1899 healthy subjects. The RIGHT Heart International NETwork (RIGHT-NET)

  2021cites this paper
• The Evolution of Risk Assessment in Pulmonary Arterial Hypertension

  2021cites this paper
• Cardiac and Pulmonary Vascular Remodeling in Endurance Open Water Swimmers Assessed by Cardiac Magnetic Resonance: Impact of Sex and Sport Discipline

  2021cites this paper
• Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension

  2021influential citation
• Insulin Resistance Is Associated with Right Ventricular Dysfunction.

  2021cites this paper
• Sex Differences in Pulmonary Hypertension

  2021cites this paper
• COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

  2021cites this paper
• Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants.

  2021cites this paper
• Molecular mechanisms of right ventricular dysfunction in pulmonary arterial hypertension: focus on the coronary vasculature, sex hormones, and glucose/lipid metabolism.

  2020cites this paper
• Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?

  2020cites this paper
• Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis

  2020cites this paper
• Upregulation of SIRT1 and FOXO3a Contributes to The Protective Role of Estrogen on HPH in Rats

  2020influential citation
• Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives.

  2020cites this paper
• Gender Differences in Portopulmonary Hypertension.

  2020cites this paper
• Sex Differences in Portopulmonary Hypertension

  2020cites this paper
• Personalisierte Medizin bei pulmonaler Hypertonie

  2019cites this paper
• Perinatal changes in estradiol and Ang II concentrations in pregnant women with pulmonary arterial hypertension and their correlation

  2019cites this paper
• Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

  2019cites this paper
• Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008–2016

  2019cites this paper
• Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension

  2018cites this paper
• Nothing but a Number? Age and Precision Treatment in Pulmonary Arterial Hypertension.

  2018cites this paper
• Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension

  2018cites this paper
• Association of hemodynamics during caesarean section, outcomes after caesarean section and hormone changes with different anesthesia in pregnant women with severe pulmonary arterial hypertension

  2018cites this paper
• Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension

  2018cites this paper
• The Complexity of Characteristics, Diagnoses and Treatment of Older Patients With Pulmonary Hypertension

  2018cites this paper
• Lumped‐parameter models of the pulmonary vasculature during the progression of pulmonary arterial hypertension

  2018cites this paper
• The role of Tumour Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) in Pulmonary Arterial Hypertension

  2018cites this paper
• The Role of Sex in the Pathophysiology of Pulmonary Hypertension.

  2018influential citation
• Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database

  2017cites this paper
• Discovery of a murine model of clinical PAH: Mission impossible?

  2017cites this paper
• Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research

  2017cites this paper
• 17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension.

  2016cites this paper
• Update in Pulmonary Vascular Disease 2015.

  2016cites this paper
• Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era: A Review.

  2016cites this paper
• Right Heart Hemodynamics in Pulmonary Hypertension　- An Echocardiography and Catheterization Study.

  2016cites this paper
• A global view of pulmonary hypertension.

  2016cites this paper
• Renin-Angiotensin-Aldosterone and Other Neurohumoral Factors in the Pathogenesis of Pulmonary Hypertension

  2016cites this paper
• Epidemiology of Pulmonary Hypertension: From Quaternary Referral Centre to the Community

  2016cites this paper
• Prognostic value of right ventricular free wall strain in pulmonary hypertension patients with pseudo-normalized tricuspid annular plane systolic excursion values

  2016cites this paper
• Incidence and prevalence of pulmonary arterial hypertension in Germany.

  2016cites this paper
• Gender-related differences in pulmonary arterial hypertension targeted drugs administration.

  2016cites this paper
• Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.

  2016cites this paper
• Guidelines and Consensus: Statement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute

  2016cites this paper
• Regulation and Function of miR-214 in Pulmonary Arterial Hypertension

  2016cites this paper
• Right Ventricular Sex Differences in Patients with Idiopathic Pulmonary Arterial Hypertension Characterised by Magnetic Resonance Imaging: Pair-Matched Case Controlled Study

  2015cites this paper
• Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.

  2015cites this paper
• Statement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute

  2015cites this paper
• Sharing clinical trial data: maximizing benefits, minimizing risk.

  2015cites this paper
• Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function

  2015cites this paper
• Update in Pulmonary Vascular Diseases 2014.

  2015cites this paper